Clinical Trial Update: The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System [Phase 1]

View source ↗

Summary

This update reports Phase 1 results from the ENTERPRISE study assessing the Enterprise self-expanding stent system for aneurysms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysm

Drugs mentioned

• Enterprise Self-Expanding Stent System

Snippet

Sponsor: Codman & Shurtleff | Conditions: Aneurysms | Phase 1 | Status: COMPLETED